Evidence map›Paper›PMID 42850323›Full record

ArticleBotanical studies2026

Carex ensiformis (C. subg. Siderosticta), a new species from southern China based on morphological and molecular evidence.

Zhaocen Lu, Yifei Lu, Xiaofeng Jin

Abstract read
In one paragraph

Article in Botanical studies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zhaocen LuCollege of Forestry (College of Life Sciences), Zhejiang A&F University, Hangzhou, Zhejiang, 311300, China.
Yifei LuCollege of Forestry (College of Life Sciences), Zhejiang A&F University, Hangzhou, Zhejiang, 311300, China.
Xiaofeng JinCollege of Forestry (College of Life Sciences), Zhejiang A&F University, Hangzhou, Zhejiang, 311300, China. docxfjin@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCarex subg. Siderosticta is one of the six subgenera recognized in the recently revised infrageneric classification of Carex based on phylogenetic studies. It represents the earliest-diverging lineage within Carex and it is sister to all remaining species in the genus. This morphologically diverse subgenus is distributed across East and Southeast Asia. Historically, the approximately 30 species of this subgenus were assigned to four morphology-based sections, namely Siderostictae, Hemiscaposae, Surculosae, and Hypolytroides.

resultsPhylogenetic analyses based on three plastid (matK, ndhF, and rps16) and two nuclear (ETS and ITS) DNA markers recovered the four individuals of Carex ensiformis as a strongly supported monophyletic lineage. Micromorphological observations revealed that C. ensiformis differs from the morphologically similar species C. damiaoshanensis in the slightly undulate anticlinal cell walls of the nutlet epidermis and a markedly shorter beak at the nutlet apex. Morphologically, the new species can be distinguished from C. damiaoshanensis by its more numerous inflorescence branches and spikes, as well as smaller utricles, nutlets, and shorter glumes.

conclusionsBoth morphological and molecular evidence reveal that Carex ensiformis is a new species belonging to subg. Siderosticta from southern China. The discovery of this species enriches our understanding of species diversity and taxonomic complexity within the subgenus, and emphasizes the importance of continued taxonomic studies in this part of Asia.

Indexed as

Carex subg. SiderostictaCyperaceaeMicromorphologyMorphologyNew speciesTaxonomy

Identifiers

PMID42850323
PMCPMC13650099

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.